Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 138

1.

Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary.

Vestbo J, Hurd SS, Agustí AG, Jones PW, Vogelmeier C, Anzueto A, Barnes PJ, Fabbri LM, Martinez FJ, Nishimura M, Stockley RA, Sin DD, Rodriguez-Roisin R.

Am J Respir Crit Care Med. 2013 Feb 15;187(4):347-65. doi: 10.1164/rccm.201204-0596PP. Epub 2012 Aug 9. Review.

PMID:
22878278
2.

The influence of obesity and obstructive sleep apnea on metabolic hormones.

Sánchez-de-la-Torre M, Mediano O, Barceló A, Piérola J, de la Peña M, Esquinas C, Miro A, Durán-Cantolla J, Agustí AG, Capote F, Marin JM, Montserrat JM, García-Río F, Barbé F.

Sleep Breath. 2012 Sep;16(3):649-56. doi: 10.1007/s11325-011-0552-7. Epub 2011 Sep 13.

PMID:
21912907
3.

Day-night variations in endothelial dysfunction markers and haemostatic factors in sleep apnoea.

Barceló A, Piérola J, de la Peña M, Esquinas C, Sanchez-de la Torre M, Ayllón O, Alonso A, Agusti AG, Barbè F.

Eur Respir J. 2012 Apr;39(4):913-8. doi: 10.1183/09031936.00039911. Epub 2011 Aug 18.

4.

Impaired circadian variation of platelet activity in patients with sleep apnea.

Barceló A, Piérola J, de la Peña M, Frontera G, Yañez A, Alonso-Fernández A, Ayllon O, Agusti AG.

Sleep Breath. 2012 Jun;16(2):355-60. doi: 10.1007/s11325-011-0501-5. Epub 2011 Mar 6.

PMID:
21380796
5.

Candidate genes for COPD in two large data sets.

Bakke PS, Zhu G, Gulsvik A, Kong X, Agusti AG, Calverley PM, Donner CF, Levy RD, Make BJ, Paré PD, Rennard SI, Vestbo J, Wouters EF, Anderson W, Lomas DA, Silverman EK, Pillai SG.

Eur Respir J. 2011 Feb;37(2):255-63. doi: 10.1183/09031936.00091709. Epub 2010 Jun 18.

6.

Non-synonymous polymorphism in the neuropeptide S precursor gene and sleep apnea.

Sánchez-de-la-Torre M, Pierola J, Vidal C, Barceló A, de la Peña M, Hussain Z, Capote F, Durán J, Agustí AG, de Lecea L, Torres G, Esquinas C, Martinez M, Barbé F.

Sleep Breath. 2011 Sep;15(3):403-8. doi: 10.1007/s11325-010-0348-1. Epub 2010 Apr 21.

PMID:
20405330
7.

Expansion of the prognostic assessment of patients with chronic obstructive pulmonary disease: the updated BODE index and the ADO index.

Puhan MA, Garcia-Aymerich J, Frey M, ter Riet G, Antó JM, Agustí AG, Gómez FP, Rodríguez-Roisín R, Moons KG, Kessels AG, Held U.

Lancet. 2009 Aug 29;374(9691):704-11. doi: 10.1016/S0140-6736(09)61301-5.

PMID:
19716962
8.

Nontypeable Haemophilus influenzae clearance by alveolar macrophages is impaired by exposure to cigarette smoke.

Martí-Lliteras P, Regueiro V, Morey P, Hood DW, Saus C, Sauleda J, Agustí AG, Bengoechea JA, Garmendia J.

Infect Immun. 2009 Oct;77(10):4232-42. doi: 10.1128/IAI.00305-09. Epub 2009 Jul 20.

9.

Characteristics of patients admitted for the first time for COPD exacerbation.

Balcells E, Antó JM, Gea J, Gómez FP, Rodríguez E, Marin A, Ferrer A, de Batlle J, Farrero E, Benet M, Orozco-Levi M, Ferrer J, Agustí AG, Gáldiz JB, Belda J, Garcia-Aymerich J; PAC-COPD Study Group.

Respir Med. 2009 Sep;103(9):1293-302. doi: 10.1016/j.rmed.2009.04.001. Epub 2009 May 8.

10.

Reflections on TORCH: potential mechanisms for the survival benefit of salmeterol/fluticasone propionate in COPD patients.

Johnson M, Agusti AG, Barnes NC.

COPD. 2008 Dec;5(6):369-75. doi: 10.1080/15412550802522924.

PMID:
19353351
11.

A controlled trial of noninvasive ventilation for chronic obstructive pulmonary disease exacerbations.

Carrera M, Marín JM, Antón A, Chiner E, Alonso ML, Masa JF, Marrades R, Sala E, Carrizo S, Giner J, Gomez-Merino E, Teran J, Disdier C, Agustí AG, Barbé F.

J Crit Care. 2009 Sep;24(3):473.e7-14. doi: 10.1016/j.jcrc.2008.08.007. Epub 2009 Jan 17.

PMID:
19327308
12.

Physical activity and clinical and functional status in COPD.

Garcia-Aymerich J, Serra I, Gómez FP, Farrero E, Balcells E, Rodríguez DA, de Batlle J, Gimeno E, Donaire-Gonzalez D, Orozco-Levi M, Sauleda J, Gea J, Rodriguez-Roisin R, Roca J, Agustí ÀG, Antó JM; Phenotype and Course of COPD (PAC-COPD) Study Group.

Chest. 2009 Jul;136(1):62-70. doi: 10.1378/chest.08-2532. Epub 2009 Mar 2.

PMID:
19255291
13.

Sustained CTL activation by murine pulmonary epithelial cells promotes the development of COPD-like disease.

Borchers MT, Wesselkamper SC, Curull V, Ramirez-Sarmiento A, Sánchez-Font A, Garcia-Aymerich J, Coronell C, Lloreta J, Agusti AG, Gea J, Howington JA, Reed MF, Starnes SL, Harris NL, Vitucci M, Eppert BL, Motz GT, Fogel K, McGraw DW, Tichelaar JW, Orozco-Levi M.

J Clin Invest. 2009 Mar;119(3):636-49. doi: 10.1172/JCI34462. Epub 2009 Feb 9.

14.

Prediction of risk of COPD exacerbations by the BODE index.

Marin JM, Carrizo SJ, Casanova C, Martinez-Camblor P, Soriano JB, Agusti AG, Celli BR.

Respir Med. 2009 Mar;103(3):373-8. doi: 10.1016/j.rmed.2008.10.004. Epub 2008 Nov 17.

15.

Lipopolysaccharide-binding protein and CD14 are increased in the bronchoalveolar lavage fluid of smokers.

Regueiro V, Campos MA, Morey P, Sauleda J, Agustí AG, Garmendia J, Bengoechea JA.

Eur Respir J. 2009 Feb;33(2):273-81. doi: 10.1183/09031936.00087708. Epub 2008 Nov 14.

16.

Increased plasma levels of asymmetric dimethylarginine and soluble CD40 ligand in patients with sleep apnea.

Barceló A, de la Peña M, Ayllón O, Vega-Agapito MV, Piérola J, Pérez G, González C, Alonso A, Agustí AG.

Respiration. 2009;77(1):85-90. doi: 10.1159/000165630. Epub 2008 Oct 22.

PMID:
18946203
17.

Airway wall thickening and emphysema show independent familial aggregation in chronic obstructive pulmonary disease.

Patel BD, Coxson HO, Pillai SG, Agustí AG, Calverley PM, Donner CF, Make BJ, Müller NL, Rennard SI, Vestbo J, Wouters EF, Hiorns MP, Nakano Y, Camp PG, Nasute Fauerbach PV, Screaton NJ, Campbell EJ, Anderson WH, Paré PD, Levy RD, Lake SL, Silverman EK, Lomas DA; International COPD Genetics Network.

Am J Respir Crit Care Med. 2008 Sep 1;178(5):500-5. doi: 10.1164/rccm.200801-059OC. Epub 2008 Jun 19.

PMID:
18565956
18.

Insulin resistance and daytime sleepiness in patients with sleep apnoea.

Barceló A, Barbé F, de la Peña M, Martinez P, Soriano JB, Piérola J, Agustí AG.

Thorax. 2008 Nov;63(11):946-50. doi: 10.1136/thx.2007.093740. Epub 2008 Jun 5.

PMID:
18535117
19.

Systemic inflammation after inspiratory loading in chronic obstructive pulmonary disease.

Fuster A, Sauleda J, Sala E, Barceló B, Pons J, Carrera M, Noguera A, Togores B, Agustí AG.

Int J Chron Obstruct Pulmon Dis. 2008;3(1):149-53.

20.

Angiotensin-converting-enzyme gene polymorphisms, smoking and chronic obstructive pulmonary disease.

Busquets X, MacFarlane NG, Heine-Suñer D, Morlá M, Torres-Juan L, Iglesias A, Lladó J, Sauleda J, Agustí AG.

Int J Chron Obstruct Pulmon Dis. 2007;2(3):329-34.

21.

Pulmonary and systemic hepatocyte and keratinocyte growth factors in patients with chronic obstructive pulmonary disease.

Sauleda J, Noguera A, Blanquer D, Pons J, López M, Villena C, Agustí AG.

Int J Chron Obstruct Pulmon Dis. 2008;3(4):719-25.

22.

Phenotypic characterisation of T-lymphocytes in COPD: abnormal CD4+CD25+ regulatory T-lymphocyte response to tobacco smoking.

Barceló B, Pons J, Ferrer JM, Sauleda J, Fuster A, Agustí AG.

Eur Respir J. 2008 Mar;31(3):555-62. Epub 2007 Dec 5.

23.

Endothelial function and circulating endothelial progenitor cells in patients with sleep apnea syndrome.

de la Peña M, Barceló A, Barbe F, Piérola J, Pons J, Rimbau E, Ayllón O, Agustí AG.

Respiration. 2008;76(1):28-32. Epub 2007 Oct 5.

PMID:
17921670
24.

Prostaglandin D synthase (beta trace) levels in sleep apnea patients with and without sleepiness.

Barceló A, de la Peña M, Barbé F, Pierola J, Bosch M, Agustí AG.

Sleep Med. 2007 Aug;8(5):509-11. Epub 2007 May 18.

PMID:
17512779
25.

Mortality in COPD: Role of comorbidities.

Sin DD, Anthonisen NR, Soriano JB, Agusti AG.

Eur Respir J. 2006 Dec;28(6):1245-57. Review.

26.

Intracellular cytokine profile of T lymphocytes in patients with chronic obstructive pulmonary disease.

Barceló B, Pons J, Fuster A, Sauleda J, Noguera A, Ferrer JM, Agustí AG.

Clin Exp Immunol. 2006 Sep;145(3):474-9.

27.

Effect of continuous positive airway pressure on the risk of road accidents in sleep apnea patients.

Barbé F, Sunyer J, de la Peña A, Pericas J, Mayoralas LR, Antó JM, Agustí AG.

Respiration. 2007;74(1):44-9. Epub 2006 Jun 26.

PMID:
16804289
28.

Expression of Toll-like receptor 2 is up-regulated in monocytes from patients with chronic obstructive pulmonary disease.

Pons J, Sauleda J, Regueiro V, Santos C, López M, Ferrer J, Agustí AG, Bengoechea JA.

Respir Res. 2006 Apr 10;7:64.

29.

Outcomes and markers in the assessment of chronic obstructive pulmonary disease.

Jones PW, Agusti AG.

Eur Respir J. 2006 Apr;27(4):822-32. Review.

30.

Antioxidant status in patients with sleep apnoea and impact of continuous positive airway pressure treatment.

Barceló A, Barbé F, de la Peña M, Vila M, Pérez G, Piérola J, Durán J, Agustí AG.

Eur Respir J. 2006 Apr;27(4):756-60.

31.

Telomere shortening in smokers with and without COPD.

Morlá M, Busquets X, Pons J, Sauleda J, MacNee W, Agustí AG.

Eur Respir J. 2006 Mar;27(3):525-8.

32.

Systemic effects of chronic obstructive pulmonary disease.

Agustí AG.

Proc Am Thorac Soc. 2005;2(4):367-70; discussion 371-2. Review.

PMID:
16267364
33.

[COPD: where are we going?].

Agustí AG.

Arch Bronconeumol. 2004 Mar;40 Suppl 1:6-8. Spanish. No abstract available.

34.

Multimedia article. Laparoscopic treatment of chronic sigmoid volvulus in a young adult.

Targarona EM, D'Ambra M, Agusti AG, Trias M.

Surg Endosc. 2005 Aug;19(8):1155. Epub 2005 May 26.

PMID:
16021382
35.

Decreased macrophage release of TGF-beta and TIMP-1 in chronic obstructive pulmonary disease.

Pons AR, Sauleda J, Noguera A, Pons J, Barceló B, Fuster A, Agustí AG.

Eur Respir J. 2005 Jul;26(1):60-6.

36.

COPD, a multicomponent disease: implications for management.

Agusti AG.

Respir Med. 2005 Jun;99(6):670-82. Epub 2005 Jan 8. Review.

37.

[Hospital treatment of chronic obstructive pulmonary disease exacerbations: an evidence-based review].

Carrera M, Sala E, Cosío BG, Agustí AG.

Arch Bronconeumol. 2005 Apr;41(4):220-9. Review. Spanish. No abstract available.

38.

Phenotypic characterisation of alveolar macrophages and peripheral blood monocytes in COPD.

Pons AR, Noguera A, Blanquer D, Sauleda J, Pons J, Agustí AG.

Eur Respir J. 2005 Apr;25(4):647-52.

40.

Blunted gamma delta T-lymphocyte response in chronic obstructive pulmonary disease.

Pons J, Sauleda J, Ferrer JM, Barceló B, Fuster A, Regueiro V, Julià MR, Agustí AG.

Eur Respir J. 2005 Mar;25(3):441-6.

41.

Neuropeptide Y and leptin in patients with obstructive sleep apnea syndrome: role of obesity.

Barceló A, Barbé F, Llompart E, de la Peña M, Durán-Cantolla J, Ladaria A, Bosch M, Guerra L, Agustí AG.

Am J Respir Crit Care Med. 2005 Jan 15;171(2):183-7. Epub 2004 Oct 29.

PMID:
15516536
42.

Effects of obesity on C-reactive protein level and metabolic disturbances in male patients with obstructive sleep apnea.

Barceló A, Barbé F, Llompart E, Mayoralas LR, Ladaria A, Bosch M, Agustí AG.

Am J Med. 2004 Jul 15;117(2):118-21. No abstract available.

PMID:
15234648
43.

Expression of adhesion molecules during apoptosis of circulating neutrophils in COPD.

Noguera A, Sala E, Pons AR, Iglesias J, MacNee W, Agustí AG.

Chest. 2004 May;125(5):1837-42.

PMID:
15136398
44.

Effects of obesity upon genioglossus structure and function in obstructive sleep apnoea.

Carrera M, Barbé F, Sauleda J, Tomás M, Gómez C, Santos C, Agustí AG.

Eur Respir J. 2004 Mar;23(3):425-9.

45.

[Steady car engine noise does not affect the cognitive abilities of sleep apnea syndrome patients].

Mayoralas LR, Barbé F, Muñoz A, Agustí AG.

Arch Bronconeumol. 2003 Sep;39(9):405-8. Spanish.

46.

Skeletal muscle changes in patients with obstructive sleep apnoea syndrome.

Sauleda J, García-Palmer FJ, Tarraga S, Maimó A, Palou A, Agustí AG.

Respir Med. 2003 Jul;97(7):804-10.

47.

Long-term (72 hours) preservation of rat lungs.

Aguiló R, Serra E, Togores B, de la Peña A, Santos C, Agustí AG.

J Thorac Cardiovasc Surg. 2003 Apr;125(4):907-12.

48.

Systemic effects of chronic obstructive pulmonary disease.

Agustí AG, Noguera A, Sauleda J, Sala E, Pons J, Busquets X.

Eur Respir J. 2003 Feb;21(2):347-60. Review.

49.

Skeletal muscle apoptosis and weight loss in chronic obstructive pulmonary disease.

Agustí AG, Sauleda J, Miralles C, Gomez C, Togores B, Sala E, Batle S, Busquets X.

Am J Respir Crit Care Med. 2002 Aug 15;166(4):485-9.

PMID:
12186825
50.

[Systemic inflammation during exacerbations of chronic obstructive pulmonary disease].

Malo O, Sauleda J, Busquets X, Miralles C, Agustí AG, Noguera A.

Arch Bronconeumol. 2002 Apr;38(4):172-6. Spanish.

Supplemental Content

Loading ...
Support Center